Provided by Tiger Fintech (Singapore) Pte. Ltd.

Savara Inc

2.61
-0.1500-5.43%
Post-market: 2.610.00000.00%17:38 EDT
Volume:901.81K
Turnover:2.39M
Market Cap:447.93M
PE:-6.13
High:2.94
Open:2.77
Low:2.57
Close:2.76
Loading ...

Savara Inc expected to post a loss of 11 cents a share - Earnings Preview

Reuters
·
10 Mar

Savara Launches Test for Autoimmune Lung Disease in US; Shares Up Pre-Bell

MT Newswires Live
·
06 Mar

Savara Announces U.S. Launch of the aPAP ClearPath™ Dried Blood Spot Test to Detect Autoimmune Pulmonary Alveolar Proteinosis (aPAP)

Business Wire
·
06 Mar

Savara Inc expected to post a loss of 11 cents a share - Earnings Preview

Reuters
·
05 Mar

Savara Announces Participation in the Leerink Global Healthcare Conference

Business Wire
·
04 Mar

Mastek In Receipt Of Administrative Warning Letter Issued By Securities And Exchange Board Of India

Reuters
·
28 Feb

BUZZ-India's Mastek gains on $85 mln order wins

Reuters
·
27 Feb

Savara Announces New Employment Inducement Grant

Business Wire
·
15 Feb

Master Tec Announces Acceptance Of Letter Of Award From Tenaga Nasional

Reuters
·
14 Feb

Positive Signs As Multiple Insiders Buy Savara Stock

Simply Wall St.
·
08 Feb

Savara Announces Manuscript on Long-Term Outcomes With Molgramostim Inhalation Solution (Molgramostim) in Autoimmune Pulmonary Alveolar Proteinosis (aPAP) Published in ERJ Open Research

Business Wire
·
30 Jan

Savara Announces Participation in Upcoming Healthcare Investor Conferences

Business Wire
·
30 Jan

Mastek Dec-Quarter Consol PAT 947.1 Mln Rupees

Reuters
·
16 Jan

DIARY- India economic, corporate events on Jan 16

Reuters
·
16 Jan

Institutional investors may adopt severe steps after Savara Inc.'s (NASDAQ:SVRA) latest 11% drop adds to a year losses

Simply Wall St.
·
11 Jan

Savara Inc. (NASDAQ:SVRA) is largely controlled by institutional shareholders who own 53% of the company

Simply Wall St.
·
29 Dec 2024